AU Patent

AU2012201428B2 — Compositions comprising azelastine and methods of use thereof

Assigned to Meda Pharmaceuticals Inc · Expires 2013-08-22 · 13y expired

What this patent protects

The present invention provides a pharmaceutical composition 5 comprising azelastine, or a pharmaceutically acceptable salt or ester thereof, at a concentration of about 0.005% to about 5.0% by weight, and one or more pharmaceutically acceptable carriers or excipients, wherein at …

USPTO Abstract

The present invention provides a pharmaceutical composition 5 comprising azelastine, or a pharmaceutically acceptable salt or ester thereof, at a concentration of about 0.005% to about 5.0% by weight, and one or more pharmaceutically acceptable carriers or excipients, wherein at least one of said pharmaceutically acceptable carriers or excipients is a taste-masking agent that masks the taste of said azelastine or salt or ester thereof such that the sensation 10 of a bitter taste by a patient caused by administration of said pharmaceutical composition to said patient is reduced or eliminated, and wherein at least one of said pharmaceutically acceptable carriers or excipients is sucralose.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012201428B2
Jurisdiction
AU
Classification
Expires
2013-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Meda Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.